butalbital, acetaminophen, and caffeine
Generic: butalbital, acetaminophen, and caffeine
Labeler: avkareDrug Facts
Product Profile
Brand Name
butalbital, acetaminophen, and caffeine
Generic Name
butalbital, acetaminophen, and caffeine
Labeler
avkare
Dosage Form
CAPSULE
Routes
Active Ingredients
acetaminophen 300 mg/1, butalbital 50 mg/1, caffeine 40 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
42291-181
Product ID
42291-181_43545fa6-9313-8af9-e063-6294a90af617
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA040885
DEA Schedule
ciii
Listing Expiration
2026-12-31
Marketing Start
2014-11-24
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
42291181
Hyphenated Format
42291-181
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
butalbital, acetaminophen, and caffeine (source: ndc)
Generic Name
butalbital, acetaminophen, and caffeine (source: ndc)
Application Number
ANDA040885 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
- 50 mg/1
- 40 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE (42291-181-01)
Packages (1)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "43545fa6-9313-8af9-e063-6294a90af617", "openfda": {"nui": ["N0000175693", "M0002177", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "KHS0AZ4JVK", "3G6A5W338E"], "rxcui": ["889520"], "spl_set_id": ["f5bbad36-6a0e-3518-3f12-138ae9f63980"], "pharm_class_cs": ["Barbiturates [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Barbiturate [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (42291-181-01)", "package_ndc": "42291-181-01", "marketing_start_date": "20141124"}], "brand_name": "Butalbital, Acetaminophen, and Caffeine", "product_id": "42291-181_43545fa6-9313-8af9-e063-6294a90af617", "dosage_form": "CAPSULE", "pharm_class": ["Barbiturate [EPC]", "Barbiturates [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Methylxanthine [EPC]", "Xanthines [CS]"], "product_ndc": "42291-181", "dea_schedule": "CIII", "generic_name": "Butalbital, Acetaminophen, and Caffeine", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Butalbital, Acetaminophen, and Caffeine", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "300 mg/1"}, {"name": "BUTALBITAL", "strength": "50 mg/1"}, {"name": "CAFFEINE", "strength": "40 mg/1"}], "application_number": "ANDA040885", "marketing_category": "ANDA", "marketing_start_date": "20141124", "listing_expiration_date": "20261231"}